← All Sponsors
SPONSOR

Medical University of Lodz

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Ulcerative ColitisInflammatory Bowel Diseases
NCT06453317 Phase 2
Recruiting

Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis
Poland View Trial →